Substance Use Disorders Among Medicare Beneficiaries: Prevalence, Mental and Physical Comorbidities, and Treatment Barriers

This study aimed to determine the prevalence of treated and untreated substance use disorders among Medicare beneficiaries, the characteristics of Medicare beneficiaries with substance use disorders, and reasons for their unmet needs. This study used data from the National Survey of Drug Use and Hea...

Full description

Saved in:
Bibliographic Details
Published in:American journal of preventive medicine 2022-08, Vol.63 (2), p.225-232
Main Authors: Parish, William J., Mark, Tami L., Weber, Ellen M., Steinberg, Deborah G.
Format: Article
Language:English
Subjects:
Alcohol use
Barriers
Beneficiaries
Comorbidity
Drug abuse
Drug use
Efficacy
Marijuana
Medical treatment
Medicare
Motivation
Polls & surveys
Prescription drugs
Psychological distress
Stigma
Substance abuse treatment
Substance use disorder
Suicidal behavior
Suicidal ideation
Suicide
Treatment needs
Uncertainty
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study aimed to determine the prevalence of treated and untreated substance use disorders among Medicare beneficiaries, the characteristics of Medicare beneficiaries with substance use disorders, and reasons for their unmet needs. This study used data from the National Survey of Drug Use and Health, 2015–2019. Substance use disorder was defined based on DSM-IV dependence or abuse criteria. Descriptive analyses were conducted in 2021, including testing for differences in unadjusted means. Approximately 1.7 million Medicare beneficiaries were estimated to have past-year substance use disorder (8% of Medicare beneficiaries aged
ISSN:0749-3797
1873-2607
DOI:10.1016/j.amepre.2022.01.021